Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Tsai, C. Frasch (1982)
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.Analytical biochemistry, 119 1
S. Sawada, T. Kawamura, Y. Masuho (1987)
Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa.Journal of general microbiology, 133 12
J. Larrick, K. Truitt, A. Raubitschek, G. Senyk, J. Wang (1983)
Characterization of human hybridomas secreting antibody to tetanus toxoid.Proceedings of the National Academy of Sciences of the United States of America, 80 20
Y. Masuho (1988)
Human monoclonal antibodies: prospects for use as passive immunotherapySerodiagnosis and Immunotherapy in Infectious Disease, 2
G. Bodey, R. Bolivar, V. Fainstein, L. Jadeja (1983)
Infections caused by Pseudomonas aeruginosa.Reviews of infectious diseases, 5 2
S. Cryz, T. Pitt, E. Fürer, R. Germanier (1984)
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosaInfection and Immunity, 44
M. Pollack, L. Young (1979)
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.The Journal of clinical investigation, 63 2
Alois Lang, E. Fürer, J. Larrick, S. Cryz (1989)
Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharidesInfection and Immunity, 57
Cryz Sj, E. Fürer, Alan Cross, A. Wegmann, R. Germanier, Jerald Sadoff (1987)
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.The Journal of clinical investigation, 80 1
Dorfman Na (1985)
The optimal technological approach to the development of human hybridomas.Journal of biological response modifiers, 4
E. Stricker, R. Tiebout, P. Lelie, W. Zeijlemaker (1985)
A Human Monoclonal IgG1λ Anti‐Hepatitis B Surface AntibodyScandinavian Journal of Immunology, 22
F. Martel, R. Bazin, S. Verrette, R. Lemieux (1988)
Characterization of higher avidity monoclonal antibodies produced by murine B-cell hybridoma variants selected for increased antigen binding of membrane Ig.Journal of immunology, 141 5
H. Zweerink, M. Gammon, C. Hutchison, J. Jackson, Donna Lombardo, Karen Miner, J. Puckett, T. Sewell, N. Sigal (1988)
Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosaInfection and Immunity, 56
O. Westphal, O. Lüderitz, F. Bister (1952)
Über die Extraktion von Bakterien mit Phenol/WasserZeitschrift für Naturforschung B, 7
S. Cryz, E. Fürer, J. Sadoff, R. Germanier (1986)
Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccineInfection and Immunity, 52
R. Moss, Y. Hsu, N. Lewiston, J. Curd, H. Milgrom, S. Hart, B. Dyer, J. Larrick (1986)
Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.The American review of respiratory disease, 133 4
Alan Cross, Alan Cross, J. Sadoff, J. Sadoff, B. Iglewski, B. Iglewski, Pamela Sokol, Pamela Sokol (1980)
Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans.The Journal of infectious diseases, 142 4
H. Towbin, T. Staehelin, J. Gordon (1979)
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences of the United States of America, 76 9
Donald Stieritz, Ian Holder (1975)
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.The Journal of infectious diseases, 131 6
S. Foung, S. Perkins, Andrew Raubitschek, J. Larrick, G. Lizak, Dianne Fishwild, E. Engleman, F. Grumet (1984)
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.Journal of immunological methods, 70 1
S. Cryz, E. Fürer, R. Germanier (1983)
Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharideInfection and Immunity, 39
Ronald Stevens, Eric Macy, Casey Morrow, Andrew Saxon (1979)
Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.Journal of immunology, 122 6
J. Mcgowan, M. Barnes, M. Finland (1975)
Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.The Journal of infectious diseases, 132 3
Y. Ichimori, K. Harada, S. Hitotsumachi, K. Tsukamoto (1987)
Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.Biochemical and biophysical research communications, 142 3
C. Bryan, Kenneth Reynolds, E. Brenner (1983)
Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.Reviews of infectious diseases, 5 4
H. Ziegler-Heitbrock, C. Reiter, J. Trenkmann, A. Fütterer, G. Riethmüller (1986)
Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.Hybridoma, 5 1
L. Young, D. Armstrong (2008)
Pseudomonas aeruginosa infections.CRC critical reviews in clinical laboratory sciences, 3 3
D. Emanuel, J. Gold, J. Colacino, C. López, U. Hämmerling (1984)
A human monoclonal antibody to cytomegalovirus (CMV).Journal of immunology, 133 4
W. Burnette (1981)
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.Analytical biochemistry, 112 2
U. Laemmli (1970)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 227
D. Jelinek, P. Lipsky (1987)
Regulation of human B lymphocyte activation, proliferation, and differentiation.Advances in immunology, 40
J. Larrick, B. Dyer, G. Senyk, S. Hart, R. Moss, David Lippman, Mark Jahnsen, Janet Wang, H. Weintraub, A. Raubitschek (1985)
In Vitro Expansion of Human B Cells for the Production of Human Monoclonal Antibodies
S. Cryz, E. Fürer, Jerald Sadoff, R. Germanier (1987)
A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.Antibiotics and chemotherapy, 39
J. Baumgartner, M. Glauser (1987)
Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.Reviews of infectious diseases, 9 1
Presenting a panel of human hybridomas secreting serospecific antibodies which confer a high degree of protection against fatal infection with Pseudomonas aeruginosa, we report an efficient approach for a systematic generation of antigen specific human monoclonal antibodies with biological activity. This approach is based on active immunization and antigen specific panning. Individuals were immunized with polysaccharides isolated from LPS of Pseudomonas aeruginosa conjugated to toxin A. Specific B cells were isolated and enriched by panning of blood samples taken at the time point with the highest frequency of fuseable cells. These cells were then transformed with Epstein-Barr virus. Arising lymphoblastoid cell lines were screened for the secretion of anti-LPS antibodies by enzyme-linked immunosorbent assay and fused to a murine-human heteromyeloma cell line. Hybridomas were selected for high levels of antibody secretion and binding to intact bacteria as determined by an immunofluorescence microscopy assay. The observation that protective capacity of an antibody was associated with its ability to bind to LPS determinants accessible on the bacterial cell surface allowed for an effective screening for therapeutically interesting human monoclonal antibodies. Out of four immunized individuals, 15 lymphoblastoid cell lines with anti-LPS activity could be isolated, and 8 hybridomas, which cover the majority of the common Pseudomonas aeruginosa serotypes, were characterized further. The generation of monoclonal anti-Pseudomonas aeruginosa toxin A, anti-Klebsiella capsular polysaccharides, and anti-Escherichia coli LPS antibodies suggests that the success of this approach is not limited to the generation of human monoclonal antibodies of a particular specificity or to the use of antigens of a particular character.
Human Antibodies – IOS Press
Published: Jan 1, 1990
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.